Introducción: La enfermedad de la COVID- 19 es una enfermedad viral que tiene una gran repercusión global, ya que puede complicarse con neumonía y falla respiratoria aguda. Se ha visto que estas complicaciones están asociadas a niveles más altos de citoquinas inflamatorias, sin embargo, no hay estudios nacionales que investiguen la función de marcadores en pacientes con COVID -19. Objetivos: Determinar las concentraciones plasmáticas de Zinc e Interleucina - 6 como biomarcadores de severidad en pacientes con COVID-19, Lima - Perú , 2021. Métodos: Estudio observacional, de corte transversal. Se realizó la medición sérica de IL 6 y Zinc en pacientes hospitalizados UCI y no UCI del Hospital Almenara y no hospitalizados del Centro de Investigación Nutricional en Lima, Perú. Se recolectó data sobre edad, sexo, síntomas principales, comorbilidades. Finalmente, se procedió al a...

In the context of SARS-CoV-2 infection, the present study aimed to determine the clinical and laboratory characteristics and serum levels of IL-6 and zinc in patients with COVID-19 according to their clinical condition in a hospital in Lima, Peru. Patients were divided into 4 groups according to the clinical condition of the disease, the group of patients hospitalized in the intensive care unit, hospitalized patients who did not require intensive care unit, COVID-19 patients who did not require hospitalization, and a control group. It was determined that 64.8% of the patients evaluated were men. Patients hospitalized in the ICU were 11.25 times more likely to have a cough and 36.7 times more likely to have a fever compared to the control group. In the group of hospitalized patients who did not require ICU, the presence of cough was 9.44 times higher than in the control group. The lowest ...